1751
|
Ma X, Hui H, Liu Z, He G, Hu J, Meng J, Guan L, Luo X. Poly-GLP-1, a novel long-lasting glucagon-like peptide-1 polymer, ameliorates hyperglycaemia by improving insulin sensitivity and increasing pancreatic beta-cell proliferation. Diabetes Obes Metab 2009; 11:953-65. [PMID: 19531053 DOI: 10.1111/j.1463-1326.2009.01070.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
AIM The clinical value of glucagon-like peptide-1 (GLP-1) is restricted because of its short half-life. To overcome this limitation, a new polymer of GLP-1 was developed by prodrug strategy, termed Poly-GLP-1, and its pharmacological properties were investigated. METHODS The in vitro release kinetics of GLP-1 from Poly-GLP-1 was analysed by Western blot. Plasma GLP-1 levels following a single administration of Poly-GLP-1 were determined by enzyme-linked immunosorbent assay. The in vitro effects of Poly-GLP-1 were evaluated using isolated pancreatic islets. The acute effects on glycaemic control and food intake were investigated in C57BL/6J mice s.c. administered with Poly-GLP-1. The chronic effects of Poly-GLP-1 on glycaemic control were further assessed in C57BL/6J and db/db mice treated twice daily for 6 weeks. RESULTS Pro-GLP-1 dose dependently increased insulin secretion and decreased glucose, but did not exhibit the insulinotropic action in isolated pancreatic islets without plasma. The glucose-lowering actions of Poly-GLP-1 (3 nmol/kg) remained no less than 12 h after a single injection. Poly-GLP-1 caused a durable restoration of glycaemic control, food intake and body weight gain in db/db mice following 6-week administration. The chronic treatment with Poly-GLP-1 improved glucose tolerance and insulin sensitivity and increased beta-cell mass and proliferation in db/db mice. There was little effect on normal mice treated in the same manner. CONCLUSIONS Our results indicated that Poly-GLP-1, a novel GLP-1 polymer, has long-lasting and potent effects on glycaemic control in vivo, and these beneficial effects may be because of improvement of insulin sensitivity and promotion of islet growth and function.
Collapse
|
1752
|
Liu Z, Xu C, Sun Y, Ye H, Du W. UP-3.111: Efficacy and Satefy of Treating Premature Ejaculation with 4 Weeks Sertraline. Urology 2009. [DOI: 10.1016/j.urology.2009.07.115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
1753
|
Liu Z, Lu T, Liao Q. O537 Data analysis of 18 cases of the pregnancy with cervical epithelial neoplasia. Int J Gynaecol Obstet 2009. [DOI: 10.1016/s0020-7292(09)60910-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
1754
|
Abazov VM, Abbott B, Abolins M, Acharya BS, Adams M, Adams T, Aguilo E, Ahsan M, Alexeev GD, Alkhazov G, Alton A, Alverson G, Alves GA, Ancu LS, Andeen T, Anzelc MS, Aoki M, Arnoud Y, Arov M, Arthaud M, Askew A, Asman B, Atramentov O, Avila C, Backusmayes J, Badaud F, Bagby L, Baldin B, Bandurin DV, Banerjee S, Barberis E, Barfuss AF, Bargassa P, Baringer P, Barreto J, Bartlett JF, Bassler U, Bauer D, Beale S, Bean A, Begalli M, Begel M, Belanger-Champagne C, Bellantoni L, Bellavance A, Benitez JA, Beri SB, Bernardi G, Bernhard R, Bertram I, Besançon M, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Blazey G, Blessing S, Bloom K, Boehnlein A, Boline D, Bolton TA, Boos EE, Borissov G, Bose T, Brandt A, Brock R, Brooijmans G, Bross A, Brown D, Bu XB, Buchholz D, Buehler M, Buescher V, Bunichev V, Burdin S, Burnett TH, Buszello CP, Calfayan P, Calpas B, Calvet S, Cammin J, Carrasco-Lizarraga MA, Carrera E, Carvalho W, Casey BCK, Castilla-Valdez H, Chakrabarti S, Chakraborty D, Chan KM, Chandra A, Cheu E, Cho DK, Choi S, Choudhary B, Christoudias T, Cihangir S, Claes D, Clutter J, Cooke M, Cooper WE, Corcoran M, Couderc F, Cousinou MC, Crépé-Renaudin S, Cutts D, Cwiok M, Das A, Davies G, De K, de Jong SJ, De La Cruz-Burelo E, Devaughan K, Déliot F, Demarteau M, Demina R, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Dominguez A, Dorland T, Dubey A, Dudko LV, Duflot L, Duggan D, Duperrin A, Dutt S, Dyshkant A, Eads M, Edmunds D, Ellison J, Elvira VD, Enari Y, Eno S, Escalier M, Evans H, Evdokimov A, Evdokimov VN, Facini G, Ferapontov AV, Ferbel T, Fiedler F, Filthaut F, Fisher W, Fisk HE, Fortner M, Fox H, Fu S, Fuess S, Gadfort T, Galea CF, Garcia C, Garcia-Bellido A, Gavrilov V, Gay P, Geist W, Geng W, Gerber CE, Gershtein Y, Gillberg D, Ginther G, Gómez B, Goussiou A, Grannis PD, Greder S, Greenlee H, Greenwood ZD, Gregores EM, Grenier G, Gris P, Grivaz JF, Grohsjean A, Grünendahl S, Grünewald MW, Guo F, Guo J, Gutierrez G, Gutierrez P, Haas A, Haefner P, Hagopian S, Haley J, Hall I, Hall RE, Han L, Harder K, Harel A, Hauptman JM, Hays J, Hebbeker T, Hedin D, Hegeman JG, Heinson AP, Heintz U, Hensel C, Heredia-De La Cruz I, Herner K, Hesketh G, Hildreth MD, Hirosky R, Hoang T, Hobbs JD, Hoeneisen B, Hohlfeld M, Hossain S, Houben P, Hu Y, Hubacek Z, Huske N, Hynek V, Iashvili I, Illingworth R, Ito AS, Jabeen S, Jaffré M, Jain S, Jakobs K, Jamin D, Jesik R, Johns K, Johnson C, Johnson M, Johnston D, Jonckheere A, Jonsson P, Juste A, Kajfasz E, Karmanov D, Kasper PA, Katsanos I, Kaushik V, Kehoe R, Kermiche S, Khalatyan N, Khanov A, Kharchilava A, Kharzheev YN, Khatidze D, Kim TJ, Kirby MH, Kirsch M, Klima B, Kohli JM, Konrath JP, Kozelov AV, Kraus J, Kuhl T, Kumar A, Kupco A, Kurca T, Kuzmin VA, Kvita J, Lacroix F, Lam D, Lammers S, Landsberg G, Lebrun P, Lee WM, Leflat A, Lellouch J, Li J, Li L, Li QZ, Lietti SM, Lim JK, Lincoln D, Linnemann J, Lipaev VV, Lipton R, Liu Y, Liu Z, Lobodenko A, Lokajicek M, Love P, Lubatti HJ, Luna-Garcia R, Lyon AL, Maciel AKA, Mackin D, Mättig P, Magaña-Villalba R, Magerkurth A, Mal PK, Malbouisson HB, Malik S, Malyshev VL, Maravin Y, Martin B, McCarthy R, McGivern CL, Meijer MM, Melnitchouk A, Mendoza L, Menezes D, Mercadante PG, Merkin M, Merritt KW, Meyer A, Meyer J, Mitrevski J, Mondal NK, Moore RW, Moulik T, Muanza GS, Mulhearn M, Mundal O, Mundim L, Nagy E, Naimuddin M, Narain M, Neal HA, Negret JP, Neustroev P, Nikolaev I, Nilsen H, Nogima H, Novaes SF, Nunnemann T, Obrant G, Ochando C, Onoprienko D, Orduna J, Oshima N, Osman N, Osta J, Otec R, Otero Y Garzón GJ, Owen M, Padilla M, Padley P, Pangilinan M, Parashar N, Park SJ, Park SK, Parsons J, Partridge R, Parua N, Patwa A, Pawloski G, Penning B, Perfilov M, Peters K, Peters Y, Pétroff P, Piegaia R, Piper J, Pleier MA, Podesta-Lerma PLM, Podstavkov VM, Pogorelov Y, Pol ME, Polozov P, Popov AV, Prado da Silva WL, Protopopescu S, Qian J, Quadt A, Quinn B, Rakitine A, Rangel MS, Ranjan K, Ratoff PN, Renkel P, Rich P, Rijssenbeek M, Ripp-Baudot I, Rizatdinova F, Robinson S, Rominsky M, Royon C, Rubinov P, Ruchti R, Safronov G, Sajot G, Sánchez-Hernández A, Sanders MP, Sanghi B, Savage G, Sawyer L, Scanlon T, Schaile D, Schamberger RD, Scheglov Y, Schellman H, Schliephake T, Schlobohm S, Schwanenberger C, Schwienhorst R, Sekaric J, Severini H, Shabalina E, Shamim M, Shary V, Shchukin AA, Shivpuri RK, Siccardi V, Simak V, Sirotenko V, Skubic P, Slattery P, Smirnov D, Snow GR, Snow J, Snyder S, Söldner-Rembold S, Sonnenschein L, Sopczak A, Sosebee M, Soustruznik K, Spurlock B, Stark J, Stolin V, Stoyanova DA, Strandberg J, Strang MA, Strauss E, Strauss M, Ströhmer R, Strom D, Stutte L, Sumowidagdo S, Svoisky P, Takahashi M, Tanasijczuk A, Taylor W, Tiller B, Titov M, Tokmenin VV, Torchiani I, Tsybychev D, Tuchming B, Tully C, Tuts PM, Unalan R, Uvarov L, Uvarov S, Uzunyan S, van den Berg PJ, Van Kooten R, van Leeuwen WM, Varelas N, Varnes EW, Vasilyev IA, Verdier P, Vertogradov LS, Verzocchi M, Vilanova D, Vint P, Vokac P, Voutilainen M, Wagner R, Wahl HD, Wang MHLS, Warchol J, Watts G, Wayne M, Weber G, Weber M, Welty-Rieger L, Wenger A, Wetstein M, White A, Wicke D, Williams MRJ, Wilson GW, Wimpenny SJ, Wobisch M, Wood DR, Wyatt TR, Xie Y, Xu C, Yacoob S, Yamada R, Yang WC, Yasuda T, Yatsunenko YA, Ye Z, Yin H, Yip K, Yoo HD, Youn SW, Yu J, Zeitnitz C, Zelitch S, Zhao T, Zhou B, Zhu J, Zielinski M, Zieminska D, Zivkovic L, Zutshi V, Zverev EG. Direct measurement of the mass difference between top and antitop quarks. PHYSICAL REVIEW LETTERS 2009; 103:132001. [PMID: 19905503 DOI: 10.1103/physrevlett.103.132001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/05/2009] [Indexed: 05/28/2023]
Abstract
We present a measurement of the mass difference between t and t[over] quarks in lepton + jets final states of tt[over] events in 1 fb;{-1} of data collected with the D0 detector from Fermilab Tevatron Collider pp[over] collisions at sqrt[s] = 1.96 TeV. The measured mass difference of 3.8 +/- 3.7 GeV is consistent with the equality of t and t[over ] masses. This is the first direct measurement of a mass difference between a quark and its antiquark partner.
Collapse
|
1755
|
Liang J, Zheng Z, Wang M, Han L, Zheng Z, Peng J, Liu Z, Wei Y. Myeloperoxidase (MPO) and interleukin-17 (IL-17) plasma levels are increased in patients with acute coronary syndromes. J Int Med Res 2009; 37:862-6. [PMID: 19589271 DOI: 10.1177/147323000903700331] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023] Open
Abstract
There are several reports of myeloperoxidase (MPO) playing an important role in acute coronary syndromes (ACS). Interleukin-17 (IL-17) is a pro-inflammatory cytokine produced by activated CD4 T cells that has a chemotactic and activating effect on neutrophils. It has also been shown that IL-17 recruits neutrophils via the release of C-X-C chemokines. The roles of MPO and IL-17 in ACS, however, have not been established. This study measured plasma MPO and IL-17 levels in 10 patients with ACS, 11 age- and sex-matched patients with stable angina and 12 healthy control subjects. Plasma MPO and IL-17 levels were significantly elevated in ACS patients compared with the patients with stable angina and the healthy control subjects. In addition, plasma MPO levels correlated with plasma IL-17 levels in all study participants. It is concluded that MPO and IL-17 are powerful indicators of acute coronary inflammation, however the data set was very small, so larger prospective studies are required.
Collapse
|
1756
|
Maraghechi P, Straatsma C, Liu Z, Zhao V, Elezzabi AY. Plasmon-assisted terahertz imaging inside metal-filled media. OPTICS EXPRESS 2009; 17:16456-16464. [PMID: 19770861 DOI: 10.1364/oe.17.016456] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
We present the application of THz plasmonics in imaging dielectric objects embedded in metal-filled media. By exploiting the time domain information from the transmitted pulse, signatures of the objects were observed. To enhance the low quality images acquired through THz time domain spectroscopy, a super-resolution image processing technique was applied. It is shown that pulse arrival time and phase magnitude information compared to the integrated instantaneous power of the transmitted pulse provides more detailed images of the embedded object.
Collapse
|
1757
|
Liu Z, Zheng J, Riedel A, Johnson J, Burke J. 7120 A retrospective review of treatment discontinuation and survival in patients with advanced renal cell carcinoma treated with sunitinib or sorafenib. EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)71453-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
1758
|
Chen Z, Amano T, Huang J, Liu Z, Keefe D, Liu L. Parthenogenetic babies from IVM eggs and tetraploid complementation. Fertil Steril 2009. [DOI: 10.1016/j.fertnstert.2009.07.094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
1759
|
Uchiyama T, Sakakibara R, Yoshiyama M, Yamamoto T, Ito T, Liu Z, Yamaguchi C, Awa Y, Yano HM, Yanagisawa M, Yamanishi T, Hattori T, Kuwabara S. Biphasic effect of apomorphine, an anti-parkinsonian drug, on bladder function in rats. Neuroscience 2009; 162:1333-8. [DOI: 10.1016/j.neuroscience.2009.06.001] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2009] [Revised: 05/27/2009] [Accepted: 06/01/2009] [Indexed: 10/20/2022]
|
1760
|
Abstract
AIMS To isolate and characterize bacteria capable of degrading nicotine from the rhizospheric soil of a tobacco plant and to use them to degrade the nicotine in tobacco solid waste. METHODS AND RESULTS A bacterium, strain S33, was newly isolated from the rhizospheric soil of a tobacco plant, and identified as Agrobacterium sp. based on morphology, physiological tests, Biolog MicroLog3 4.20 system and 16S rRNA gene sequence. Using nicotine as the sole source of carbon and nitrogen in the medium, it grew optimally with 1.0 g l(-1) of nicotine at 30 degrees C and pH 7.0, and nicotine was completely degraded within 6 h. The resting cells prepared from the glucose-ammonium medium or LB medium could not degrade nicotine within 10 h, while those prepared from the nicotine medium could completely degrade 3 g l(-1) of nicotine in 1.5 h at a maximal rate of 1.23 g nicotine h(-1) g(-1) dry cell. Using the medium containing nicotine, glucose and ammonium simultaneously to cultivate strain S33, the resting cells could degrade 98.87% of nicotine in tobacco solid waste with the concentration as 30 mg nicotine g(-1) dry weight tobacco solid waste within 7 h at a maximal rate of 0.46 g nicotine h(-1) g(-1) dry cell. CONCLUSIONS This is the first report that Agrobacterium sp. has the ability to degrade nicotine. Agrobacterium sp. S33 could use nicotine as the sole source of carbon and nitrogen. The use of resting cells of the strain S33 prepared from the nicotine-glucose-ammonium medium was an effective method to degrade nicotine and detoxify tobacco solid waste. SIGNIFICANCE AND IMPACT OF THE STUDY Nicotine in tobacco wastes is both toxic and harmful to human health and the environment. This study showed that Agrobacterium sp. S33 may be suitable for the disposal of tobacco wastes and reducing the nicotine content in tobacco leaves.
Collapse
|
1761
|
Abazov VM, Abbott B, Abolins M, Acharya BS, Adams M, Adams T, Aguilo E, Ahsan M, Alexeev GD, Alkhazov G, Alton A, Alverson G, Alves GA, Ancu LS, Andeen T, Anzelc MS, Aoki M, Arnoud Y, Arov M, Arthaud M, Askew A, Asman B, Atramentov O, Avila C, BackusMayes J, Badaud F, Bagby L, Baldin B, Bandurin DV, Banerjee P, Banerjee S, Barberis E, Barfuss AF, Bargassa P, Baringer P, Barreto J, Bartlett JF, Bassler U, Bauer D, Beale S, Bean A, Begalli M, Begel M, Belanger-Champagne C, Bellantoni L, Bellavance A, Benitez JA, Beri SB, Bernardi G, Bernhard R, Bertram I, Besançon M, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Blazey G, Blessing S, Bloom K, Boehnlein A, Boline D, Bolton TA, Boos EE, Borissov G, Bose T, Brandt A, Brock R, Brooijmans G, Bross A, Brown D, Bu XB, Buchanan NJ, Buchholz D, Buehler M, Buescher V, Bunichev V, Burdin S, Burnett TH, Buszello CP, Calfayan P, Calpas B, Calvet S, Cammin J, Carrasco-Lizarraga MA, Carrera E, Carvalho W, Casey BCK, Castilla-Valdez H, Chakrabarti S, Chakraborty D, Chan KM, Chandra A, Cheu E, Cho DK, Choi S, Choudhary B, Christofek L, Christoudias T, Cihangir S, Claes D, Clutter J, Coadou Y, Cooke M, Cooper WE, Corcoran M, Couderc F, Cousinou MC, Crépé-Renaudin S, Cuplov V, Cutts D, Cwiok M, Das A, Davies G, De K, de Jong SJ, De La Cruz-Burelo E, DeVaughan K, Déliot F, Demarteau M, Demina R, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Dominguez A, Dorland T, Dubey A, Dudko LV, Duflot L, Duggan D, Duperrin A, Dutt S, Dyshkant A, Eads M, Edmunds D, Ellison J, Elvira VD, Enari Y, Eno S, Ermolov P, Escalier M, Evans H, Evdokimov A, Evdokimov VN, Ferapontov AV, Ferbel T, Fiedler F, Filthaut F, Fisher W, Fisk HE, Fortner M, Fox H, Fu S, Fuess S, Gadfort T, Galea CF, Garcia-Bellido A, Gavrilov V, Gay P, Geist W, Geng W, Gerber CE, Gershtein Y, Gillberg D, Ginther G, Gómez B, Goussiou A, Grannis PD, Greder S, Greenlee H, Greenwood ZD, Gregores EM, Grenier G, Gris P, Grivaz JF, Grohsjean A, Grünendahl S, Grünewald MW, Guo F, Guo J, Gutierrez G, Gutierrez P, Haas A, Hadley NJ, Haefner P, Hagopian S, Haley J, Hall I, Hall RE, Han L, Harder K, Harel A, Hauptman JM, Hays J, Hebbeker T, Hedin D, Hegeman JG, Heinson AP, Heintz U, Hensel C, Herner K, Hesketh G, Hildreth MD, Hirosky R, Hoang T, Hobbs JD, Hoeneisen B, Hohlfeld M, Hossain S, Houben P, Hu Y, Hubacek Z, Huske N, Hynek V, Iashvili I, Illingworth R, Ito AS, Jabeen S, Jaffré M, Jain S, Jakobs K, Jamin D, Jarvis C, Jesik R, Johns K, Johnson C, Johnson M, Johnston D, Jonckheere A, Jonsson P, Juste A, Kajfasz E, Karmanov D, Kasper PA, Katsanos I, Kaushik V, Kehoe R, Kermiche S, Khalatyan N, Khanov A, Kharchilava A, Kharzheev YN, Khatidze D, Kim TJ, Kirby MH, Kirsch M, Klima B, Kohli JM, Konrath JP, Kozelov AV, Kraus J, Kuhl T, Kumar A, Kupco A, Kurca T, Kuzmin VA, Kvita J, Lacroix F, Lam D, Lammers S, Landsberg G, Lebrun P, Lee WM, Leflat A, Lellouch J, Li J, Li L, Li QZ, Lietti SM, Lim JK, Lincoln D, Linnemann J, Lipaev VV, Lipton R, Liu Y, Liu Z, Lobodenko A, Lokajicek M, Love P, Lubatti HJ, Luna-Garcia R, Lyon AL, Maciel AKA, Mackin D, Mättig P, Magerkurth A, Mal PK, Malbouisson HB, Malik S, Malyshev VL, Maravin Y, Martin B, McCarthy R, McGivern CL, Meijer MM, Melnitchouk A, Mendoza L, Mercadante PG, Merkin M, Merritt KW, Meyer A, Meyer J, Mitrevski J, Mommsen RK, Mondal NK, Moore RW, Moulik T, Muanza GS, Mulhearn M, Mundal O, Mundim L, Nagy E, Naimuddin M, Narain M, Neal HA, Negret JP, Neustroev P, Nilsen H, Nogima H, Novaes SF, Nunnemann T, O'Neil DC, Obrant G, Ochando C, Onoprienko D, Orduna J, Oshima N, Osman N, Osta J, Otec R, Otero Y Garzón GJ, Owen M, Padilla M, Padley P, Pangilinan M, Parashar N, Park SJ, Park SK, Parsons J, Partridge R, Parua N, Patwa A, Pawloski G, Penning B, Perfilov M, Peters K, Peters Y, Pétroff P, Piegaia R, Piper J, Pleier MA, Podesta-Lerma PLM, Podstavkov VM, Pogorelov Y, Pol ME, Polozov P, Popov AV, Potter C, Prado da Silva WL, Prosper HB, Protopopescu S, Qian J, Quadt A, Quinn B, Rakitine A, Rangel MS, Ranjan K, Ratoff PN, Renkel P, Rich P, Rijssenbeek M, Ripp-Baudot I, Rizatdinova F, Robinson S, Rodrigues RF, Rominsky M, Royon C, Rubinov P, Ruchti R, Safronov G, Sajot G, Sánchez-Hernández A, Sanders MP, Sanghi B, Savage G, Sawyer L, Scanlon T, Schaile D, Schamberger RD, Scheglov Y, Schellman H, Schliephake T, Schlobohm S, Schwanenberger C, Schwienhorst R, Sekaric J, Severini H, Shabalina E, Shamim M, Shary V, Shchukin AA, Shivpuri RK, Siccardi V, Simak V, Sirotenko V, Skubic P, Slattery P, Smirnov D, Snow GR, Snow J, Snyder S, Söldner-Rembold S, Sonnenschein L, Sopczak A, Sosebee M, Soustruznik K, Spurlock B, Stark J, Stolin V, Stoyanova DA, Strandberg J, Strandberg S, Strang MA, Strauss E, Strauss M, Ströhmer R, Strom D, Stutte L, Sumowidagdo S, Svoisky P, Takahashi M, Tanasijczuk A, Taylor W, Tiller B, Tissandier F, Titov M, Tokmenin VV, Torchiani I, Tsybychev D, Tuchming B, Tully C, Tuts PM, Unalan R, Uvarov L, Uvarov S, Uzunyan S, Vachon B, van den Berg PJ, Van Kooten R, van Leeuwen WM, Varelas N, Varnes EW, Vasilyev IA, Verdier P, Vertogradov LS, Verzocchi M, Vilanova D, Vint P, Vokac P, Voutilainen M, Wagner R, Wahl HD, Wang MHLS, Warchol J, Watts G, Wayne M, Weber G, Weber M, Welty-Rieger L, Wenger A, Wetstein M, White A, Wicke D, Williams MRJ, Wilson GW, Wimpenny SJ, Wobisch M, Wood DR, Wyatt TR, Xie Y, Xu C, Yacoob S, Yamada R, Yang WC, Yasuda T, Yatsunenko YA, Ye Z, Yin H, Yip K, Yoo HD, Youn SW, Yu J, Zeitnitz C, Zelitch S, Zhao T, Zhou B, Zhu J, Zielinski M, Zieminska D, Zivkovic L, Zutshi V, Zverev EG. Observation of single top-quark production. PHYSICAL REVIEW LETTERS 2009; 103:092001. [PMID: 19792787 DOI: 10.1103/physrevlett.103.092001] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/04/2009] [Revised: 04/10/2009] [Indexed: 05/28/2023]
Abstract
We report observation of the electroweak production of single top quarks in pp[over ] collisions at sqrt[s]=1.96 TeV based on 2.3 fb(-1) of data collected by the D0 detector at the Fermilab Tevatron Collider. Using events containing an isolated electron or muon and missing transverse energy, together with jets originating from the fragmentation of b quarks, we measure a cross section of sigma(pp[over ]--> tb + X, tqb + X) = 3.94 + or - 0.88 pb. The probability to measure a cross section at this value or higher in the absence of signal is 2.5 x 10(-7), corresponding to a 5.0 standard deviation significance for the observation.
Collapse
|
1762
|
Venkatachalam S, Zhu H, Masarapu C, Hung K, Liu Z, Suenaga K, Wei B. In-situ formation of sandwiched structures of nanotube/CuxOy/Cu composites for lithium battery applications. ACS NANO 2009; 3:2177-2184. [PMID: 19637892 DOI: 10.1021/nn900432u] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
Development of materials and structures leading to lithium ion batteries with high energy and power density is a major requirement for catering to the power needs of present day electronic industry. Here, we report an in situ formation of a sandwiched structure involving single-walled carbon nanotube film, copper oxide, and copper during the direct synthesis of nanotube macrofilms over copper foils and their electrochemical performance in lithium ion batteries. The sandwiched structure showed a remarkably high reversible capacity of 220 mAh/g at a high cycling current of 18.6 A/g (50 C), leading to a significantly improved electrochemical performance which is extremely high compared to pure carbon nanotube and any other carbon based materials.
Collapse
|
1763
|
Abazov VM, Abbott B, Abolins M, Acharya BS, Adams M, Adams T, Aguilo E, Ahsan M, Alexeev GD, Alkhazov G, Alton A, Alverson G, Alves GA, Ancu LS, Andeen T, Anzelc MS, Aoki M, Arnoud Y, Arov M, Arthaud M, Askew A, Asman B, Atramentov O, Avila C, BackusMayes J, Badaud F, Bagby L, Baldin B, Bandurin DV, Banerjee S, Barberis E, Barfuss AF, Bargassa P, Baringer P, Barreto J, Bartlett JF, Bassler U, Bauer D, Beale S, Bean A, Begalli M, Begel M, Belanger-Champagne C, Bellantoni L, Bellavance A, Benitez JA, Beri SB, Bernardi G, Bernhard R, Bertram I, Besançon M, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Blazey G, Blessing S, Bloom K, Boehnlein A, Boline D, Bolton TA, Boos EE, Borissov G, Bose T, Brandt A, Brock R, Brooijmans G, Bross A, Brown D, Bu XB, Buchholz D, Buehler M, Buescher V, Bunichev V, Burdin S, Burnett TH, Buszello CP, Calfayan P, Calpas B, Calvet S, Cammin J, Carrasco-Lizarraga MA, Carrera E, Carvalho W, Casey BCK, Castilla-Valdez H, Chakrabarti S, Chakraborty D, Chan KM, Chandra A, Cheu E, Cho DK, Choi S, Choudhary B, Christoudias T, Cihangir S, Claes D, Clutter J, Cooke M, Cooper WE, Corcoran M, Couderc F, Cousinou MC, Crépé-Renaudin S, Cuplov V, Cutts D, Cwiok M, Das A, Davies G, De K, de Jong SJ, De La Cruz-Burelo E, DeVaughan K, Déliot F, Demarteau M, Demina R, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Dominguez A, Dorland T, Dubey A, Dudko LV, Duflot L, Duggan D, Duperrin A, Dutt S, Dyshkant A, Eads M, Edmunds D, Ellison J, Elvira VD, Enari Y, Eno S, Ermolov P, Escalier M, Evans H, Evdokimov A, Evdokimov VN, Facini G, Ferapontov AV, Ferbel T, Fiedler F, Filthaut F, Fisher W, Fisk HE, Fortner M, Fox H, Fu S, Fuess S, Gadfort T, Galea CF, Garcia-Bellido A, Gavrilov V, Gay P, Geist W, Geng W, Gerber CE, Gershtein Y, Gillberg D, Ginther G, Gómez B, Goussiou A, Grannis PD, Greder S, Greenlee H, Greenwood ZD, Gregores EM, Grenier G, Gris P, Grivaz JF, Grohsjean A, Grünendahl S, Grünewald MW, Guo F, Guo J, Gutierrez G, Gutierrez P, Haas A, Hadley NJ, Haefner P, Hagopian S, Haley J, Hall I, Hall RE, Han L, Harder K, Harel A, Hauptman JM, Hays J, Hebbeker T, Hedin D, Hegeman JG, Heinson AP, Heintz U, Hensel C, Heredia-De La Cruz I, Herner K, Hesketh G, Hildreth MD, Hirosky R, Hoang T, Hobbs JD, Hoeneisen B, Hohlfeld M, Hossain S, Houben P, Hu Y, Hubacek Z, Huske N, Hynek V, Iashvili I, Illingworth R, Ito AS, Jabeen S, Jaffré M, Jain S, Jakobs K, Jamin D, Jarvis C, Jesik R, Johns K, Johnson C, Johnson M, Johnston D, Jonckheere A, Jonsson P, Juste A, Kajfasz E, Karmanov D, Kasper PA, Katsanos I, Kaushik V, Kehoe R, Kermiche S, Khalatyan N, Khanov A, Kharchilava A, Kharzheev YN, Khatidze D, Kim TJ, Kirby MH, Kirsch M, Klima B, Kohli JM, Konrath JP, Kozelov AV, Kraus J, Kuhl T, Kumar A, Kupco A, Kurca T, Kuzmin VA, Kvita J, Lacroix F, Lam D, Lammers S, Landsberg G, Lebrun P, Lee WM, Leflat A, Lellouch J, Li J, Li L, Li QZ, Lietti SM, Lim JK, Lincoln D, Linnemann J, Lipaev VV, Lipton R, Liu Y, Liu Z, Lobodenko A, Lokajicek M, Love P, Lubatti HJ, Luna-Garcia R, Lyon AL, Maciel AKA, Mackin D, Mättig P, Magerkurth A, Mal PK, Malbouisson HB, Malik S, Malyshev VL, Maravin Y, Martin B, McCarthy R, McGivern CL, Meijer MM, Melnitchouk A, Mendoza L, Menezes D, Mercadante PG, Merkin M, Merritt KW, Meyer A, Meyer J, Mitrevski J, Mommsen RK, Mondal NK, Moore RW, Moulik T, Muanza GS, Mulhearn M, Mundal O, Mundim L, Nagy E, Naimuddin M, Narain M, Neal HA, Negret JP, Neustroev P, Nilsen H, Nogima H, Novaes SF, Nunnemann T, Obrant G, Ochando C, Onoprienko D, Orduna J, Oshima N, Osman N, Osta J, Otec R, Otero y Garzón GJ, Owen M, Padilla M, Padley P, Pangilinan M, Parashar N, Park SJ, Park SK, Parsons J, Partridge R, Parua N, Patwa A, Pawloski G, Penning B, Perfilov M, Peters K, Peters Y, Pétroff P, Piegaia R, Piper J, Pleier MA, Podesta-Lerma PLM, Podstavkov VM, Pogorelov Y, Pol ME, Polozov P, Popov AV, Potter C, Prado da Silva WL, Protopopescu S, Qian J, Quadt A, Quinn B, Rakitine A, Rangel MS, Ranjan K, Ratoff PN, Renkel P, Rich P, Rijssenbeek M, Ripp-Baudot I, Rizatdinova F, Robinson S, Rodrigues RF, Rominsky M, Royon C, Rubinov P, Ruchti R, Safronov G, Sajot G, Sánchez-Hernández A, Sanders MP, Sanghi B, Savage G, Sawyer L, Scanlon T, Schaile D, Schamberger RD, Scheglov Y, Schellman H, Schliephake T, Schlobohm S, Schwanenberger C, Schwienhorst R, Sekaric J, Severini H, Shabalina E, Shamim M, Shary V, Shchukin AA, Shivpuri RK, Siccardi V, Simak V, Sirotenko V, Skubic P, Slattery P, Smirnov D, Snow GR, Snow J, Snyder S, Söldner-Rembold S, Sonnenschein L, Sopczak A, Sosebee M, Soustruznik K, Spurlock B, Stark J, Stolin V, Stoyanova DA, Strandberg J, Strandberg S, Strang MA, Strauss E, Strauss M, Ströhmer R, Strom D, Stutte L, Sumowidagdo S, Svoisky P, Takahashi M, Tanasijczuk A, Taylor W, Tiller B, Tissandier F, Titov M, Tokmenin VV, Torchiani I, Tsybychev D, Tuchming B, Tully C, Tuts PM, Unalan R, Uvarov L, Uvarov S, Uzunyan S, Vachon B, van den Berg PJ, Van Kooten R, van Leeuwen WM, Varelas N, Varnes EW, Vasilyev IA, Verdier P, Vertogradov LS, Verzocchi M, Vilanova D, Vint P, Vokac P, Voutilainen M, Wagner R, Wahl HD, Wang MHLS, Warchol J, Watts G, Wayne M, Weber G, Weber M, Welty-Rieger L, Wenger A, Wetstein M, White A, Wicke D, Williams MRJ, Wilson GW, Wimpenny SJ, Wobisch M, Wood DR, Wyatt TR, Xie Y, Xu C, Yacoob S, Yamada R, Yang WC, Yasuda T, Yatsunenko YA, Ye Z, Yin H, Yip K, Yoo HD, Youn SW, Yu J, Zeitnitz C, Zelitch S, Zhao T, Zhou B, Zhu J, Zielinski M, Zieminska D, Zivkovic L, Zutshi V, Zverev EG. Search for dark photons from supersymmetric hidden valleys. PHYSICAL REVIEW LETTERS 2009; 103:081802. [PMID: 19792716 DOI: 10.1103/physrevlett.103.081802] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/11/2009] [Indexed: 05/28/2023]
Abstract
We search for a new light gauge boson, a dark photon, with the D0 experiment. In the model we consider, supersymmetric partners are pair produced and cascade to the lightest neutralinos that can decay into the hidden sector state plus either a photon or a dark photon. The dark photon decays through its mixing with a photon into fermion pairs. We therefore investigate a previously unexplored final state that contains a photon, two spatially close leptons, and large missing transverse energy. We do not observe any evidence for dark photons and set a limit on their production.
Collapse
|
1764
|
Myers SL, Lobdell DT, Liu Z, Xia Y, Ren H, Li Y, Kwok RK, Mumford JL, Mendola P. Maternal drinking water arsenic exposure and perinatal outcomes in Inner Mongolia, China. J Epidemiol Community Health 2009; 64:325-9. [DOI: 10.1136/jech.2008.084392] [Citation(s) in RCA: 60] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
1765
|
Abazov VM, Abbott B, Abolins M, Acharya BS, Adams M, Adams T, Aguilo E, Ahsan M, Alexeev GD, Alkhazov G, Alton A, Alverson G, Alves GA, Ancu LS, Andeen T, Anzelc MS, Aoki M, Arnoud Y, Arov M, Arthaud M, Askew A, Asman B, Atramentov O, Avila C, Backusmayes J, Badaud F, Bagby L, Baldin B, Bandurin DV, Banerjee S, Barberis E, Barfuss AF, Bargassa P, Baringer P, Barreto J, Bartlett JF, Bassler U, Bauer D, Beale S, Bean A, Begalli M, Begel M, Belanger-Champagne C, Bellantoni L, Bellavance A, Benitez JA, Beri SB, Bernardi G, Bernhard R, Bertram I, Besançon M, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Blazey G, Blessing S, Bloom K, Boehnlein A, Boline D, Bolton TA, Boos EE, Borissov G, Bose T, Brandt A, Brock R, Brooijmans G, Bross A, Brown D, Bu XB, Buchholz D, Buehler M, Buescher V, Bunichev V, Burdin S, Burnett TH, Buszello CP, Calfayan P, Calpas B, Calvet S, Cammin J, Carrasco-Lizarraga MA, Carrera E, Carvalho W, Casey BCK, Castilla-Valdez H, Chakrabarti S, Chakraborty D, Chan KM, Chandra A, Cheu E, Cho DK, Choi S, Choudhary B, Christoudias T, Cihangir S, Claes D, Clutter J, Cooke M, Cooper WE, Corcoran M, Couderc F, Cousinou MC, Crépé-Renaudin S, Cutts D, Cwiok M, Das A, Davies G, De K, de Jong SJ, De La Cruz-Burelo E, Devaughan K, Déliot F, Demarteau M, Demina R, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Dominguez A, Dorland T, Dubey A, Dudko LV, Duflot L, Duggan D, Duperrin A, Dutt S, Dyshkant A, Eads M, Edmunds D, Ellison J, Elvira VD, Enari Y, Eno S, Escalier M, Evans H, Evdokimov A, Evdokimov VN, Facini G, Ferapontov AV, Ferbel T, Fiedler F, Filthaut F, Fisher W, Fisk HE, Fortner M, Fox H, Fu S, Fuess S, Gadfort T, Galea CF, Garcia-Bellido A, Gavrilov V, Gay P, Geist W, Geng W, Gerber CE, Gershtein Y, Gillberg D, Ginther G, Gómez B, Goussiou A, Grannis PD, Greder S, Greenlee H, Greenwood ZD, Gregores EM, Grenier G, Gris P, Grivaz JF, Grohsjean A, Grünendahl S, Grünewald MW, Guo F, Guo J, Gutierrez G, Gutierrez P, Haas A, Haefner P, Hagopian S, Haley J, Hall I, Hall RE, Han L, Harder K, Harel A, Hauptman JM, Hays J, Hebbeker T, Hedin D, Hegeman JG, Heinson AP, Heintz U, Hensel C, Heredia-De La Cruz I, Herner K, Hesketh G, Hildreth MD, Hirosky R, Hoang T, Hobbs JD, Hoeneisen B, Hohlfeld M, Hossain S, Houben P, Hu Y, Hubacek Z, Huske N, Hynek V, Iashvili I, Illingworth R, Ito AS, Jabeen S, Jaffré M, Jain S, Jakobs K, Jamin D, Jesik R, Johns K, Johnson C, Johnson M, Johnston D, Jonckheere A, Jonsson P, Juste A, Kajfasz E, Karmanov D, Kasper PA, Katsanos I, Kaushik V, Kehoe R, Kermiche S, Khalatyan N, Khanov A, Kharchilava A, Kharzheev YN, Khatidze D, Kim TJ, Kirby MH, Kirsch M, Klima B, Kohli JM, Konrath JP, Kozelov AV, Kraus J, Kuhl T, Kumar A, Kupco A, Kurca T, Kuzmin VA, Kvita J, Lacroix F, Lam D, Lammers S, Landsberg G, Lebrun P, Lee WM, Leflat A, Lellouch J, Li J, Li L, Li QZ, Lietti SM, Lim JK, Lincoln D, Linnemann J, Lipaev VV, Lipton R, Liu Y, Liu Z, Lobodenko A, Lokajicek M, Love P, Lubatti HJ, Luna-Garcia R, Lyon AL, Maciel AKA, Mackin D, Mättig P, Magaña-Villalba R, Magerkurth A, Mal PK, Malbouisson HB, Malik S, Malyshev VL, Maravin Y, Martin B, McCarthy R, McGivern CL, Meijer MM, Melnitchouk A, Mendoza L, Menezes D, Mercadante PG, Merkin M, Merritt KW, Meyer A, Meyer J, Mitrevski J, Mondal NK, Moore RW, Moulik T, Muanza GS, Mulhearn M, Mundal O, Mundim L, Nagy E, Naimuddin M, Narain M, Neal HA, Negret JP, Neustroev P, Nilsen H, Nogima H, Novaes SF, Nunnemann T, Obrant G, Ochando C, Onoprienko D, Orduna J, Oshima N, Osman N, Osta J, Otec R, Otero Y Garzón GJ, Owen M, Padilla M, Padley P, Pangilinan M, Parashar N, Park SJ, Park SK, Parsons J, Partridge R, Parua N, Patwa A, Pawloski G, Penning B, Perfilov M, Peters K, Peters Y, Pétroff P, Piegaia R, Piper J, Pleier MA, Podesta-Lerma PLM, Podstavkov VM, Pogorelov Y, Pol ME, Polozov P, Popov AV, da Silva WLP, Protopopescu S, Qian J, Quadt A, Quinn B, Rakitine A, Rangel MS, Ranjan K, Ratoff PN, Renkel P, Rich P, Rijssenbeek M, Ripp-Baudot I, Rizatdinova F, Robinson S, Rominsky M, Royon C, Rubinov P, Ruchti R, Safronov G, Sajot G, Sánchez-Hernández A, Sanders MP, Sanghi B, Savage G, Sawyer L, Scanlon T, Schaile D, Schamberger RD, Scheglov Y, Schellman H, Schliephake T, Schlobohm S, Schwanenberger C, Schwienhorst R, Sekaric J, Severini H, Shabalina E, Shamim M, Shary V, Shchukin AA, Shivpuri RK, Siccardi V, Simak V, Sirotenko V, Skubic P, Slattery P, Smirnov D, Snow GR, Snow J, Snyder S, Söldner-Rembold S, Sonnenschein L, Sopczak A, Sosebee M, Soustruznik K, Spurlock B, Stark J, Stolin V, Stoyanova DA, Strandberg J, Strang MA, Strauss E, Strauss M, Ströhmer R, Strom D, Stutte L, Sumowidagdo S, Svoisky P, Takahashi M, Tanasijczuk A, Taylor W, Tiller B, Titov M, Tokmenin VV, Torchiani I, Tsybychev D, Tuchming B, Tully C, Tuts PM, Unalan R, Uvarov L, Uvarov S, Uzunyan S, van den Berg PJ, Van Kooten R, van Leeuwen WM, Varelas N, Varnes EW, Vasilyev IA, Verdier P, Vertogradov LS, Verzocchi M, Vilanova D, Vint P, Vokac P, Voutilainen M, Wagner R, Wahl HD, Wang MHLS, Warchol J, Watts G, Wayne M, Weber G, Weber M, Welty-Rieger L, Wenger A, Wetstein M, White A, Wicke D, Williams MRJ, Wilson GW, Wimpenny SJ, Wobisch M, Wood DR, Wyatt TR, Xie Y, Xu C, Yacoob S, Yamada R, Yang WC, Yasuda T, Yatsunenko YA, Ye Z, Yin H, Yip K, Yoo HD, Youn SW, Yu J, Zeitnitz C, Zelitch S, Zhao T, Zhou B, Zhu J, Zielinski M, Zieminska D, Zivkovic L, Zutshi V, Zverev EG. Search for resonant pair production of neutral long-lived particles decaying to bb in pp collisions at square root(S)=1.96 TeV. PHYSICAL REVIEW LETTERS 2009; 103:071801. [PMID: 19792632 DOI: 10.1103/physrevlett.103.071801] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/09/2009] [Indexed: 05/28/2023]
Abstract
We report on a first search for resonant pair production of neutral long-lived particles (NLLP) which each decay to a bb pair, using 3.6 fb(-1) of data recorded with the D0 detector at the Fermilab Tevatron collider. We search for pairs of displaced vertices in the tracking detector at radii in the range 1.6-20 cm from the beam axis. No significant excess is observed above background, and upper limits are set on the production rate in a hidden-valley benchmark model for a range of Higgs boson masses and NLLP masses and lifetimes.
Collapse
|
1766
|
McCarthy PW, Liu Z, Heusch AI, Cascioli V. Assessment of humidity and temperature sensors and their application to seating. J Med Eng Technol 2009; 33:449-53. [PMID: 19479607 DOI: 10.1080/03091900902952626] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
1767
|
Abazov VM, Abbott B, Abolins M, Acharya BS, Adams M, Adams T, Aguilo E, Ahsan M, Alexeev GD, Alkhazov G, Alton A, Alverson G, Alves GA, Ancu LS, Andeen T, Anzelc MS, Aoki M, Arnoud Y, Arov M, Arthaud M, Askew A, Asman B, Atramentov O, Avila C, Backusmayes J, Badaud F, Bagby L, Baldin B, Bandurin DV, Banerjee S, Barberis E, Barfuss AF, Bargassa P, Baringer P, Barreto J, Bartlett JF, Bassler U, Bauer D, Beale S, Bean A, Begalli M, Begel M, Belanger-Champagne C, Bellantoni L, Bellavance A, Benitez JA, Beri SB, Bernardi G, Bernhard R, Bertram I, Besançon M, Beuselinck R, Bezzubov VA, Bhat PC, Bhatnagar V, Blazey G, Blessing S, Bloom K, Boehnlein A, Boline D, Bolton TA, Boos EE, Borissov G, Bose T, Brandt A, Brock R, Brooijmans G, Bross A, Brown D, Bu XB, Buchholz D, Buehler M, Buescher V, Bunichev V, Burdin S, Burnett TH, Buszello CP, Calfayan P, Calpas B, Calvet S, Cammin J, Carrasco-Lizarraga MA, Carrera E, Carvalho W, Casey BCK, Castilla-Valdez H, Chakrabarti S, Chakraborty D, Chan KM, Chandra A, Cheu E, Cho DK, Choi S, Choudhary B, Christoudias T, Cihangir S, Claes D, Clutter J, Cooke M, Cooper WE, Corcoran M, Couderc F, Cousinou MC, Crépé-Renaudin S, Cutts D, Cwiok M, Das A, Davies G, De K, de Jong SJ, De La Cruz-Burelo E, Devaughan K, Déliot F, Demarteau M, Demina R, Denisov D, Denisov SP, Desai S, Diehl HT, Diesburg M, Dominguez A, Dorland T, Dubey A, Dudko LV, Duflot L, Duggan D, Duperrin A, Dutt S, Dyshkant A, Eads M, Edmunds D, Ellison J, Elvira VD, Enari Y, Eno S, Escalier M, Evans H, Evdokimov A, Evdokimov VN, Facini G, Ferapontov AV, Ferbel T, Fiedler F, Filthaut F, Fisher W, Fisk HE, Fortner M, Fox H, Fu S, Fuess S, Gadfort T, Galea CF, Garcia-Bellido A, Gavrilov V, Gay P, Geist W, Geng W, Gerber CE, Gershtein Y, Gillberg D, Ginther G, Gómez B, Goussiou A, Grannis PD, Greder S, Greenlee H, Greenwood ZD, Gregores EM, Grenier G, Gris P, Grivaz JF, Grohsjean A, Grünendahl S, Grünewald MW, Guo F, Guo J, Gutierrez G, Gutierrez P, Haas A, Haefner P, Hagopian S, Haley J, Hall I, Hall RE, Han L, Harder K, Harel A, Hauptman JM, Hays J, Hebbeker T, Hedin D, Hegeman JG, Heinson AP, Heintz U, Hensel C, Heredia-De La Cruz I, Herner K, Hesketh G, Hildreth MD, Hirosky R, Hoang T, Hobbs JD, Hoeneisen B, Hohlfeld M, Hossain S, Houben P, Hu Y, Hubacek Z, Huske N, Hynek V, Iashvili I, Illingworth R, Ito AS, Jabeen S, Jaffré M, Jain S, Jakobs K, Jamin D, Jesik R, Johns K, Johnson C, Johnson M, Johnston D, Jonckheere A, Jonsson P, Juste A, Kajfasz E, Karmanov D, Kasper PA, Katsanos I, Kaushik V, Kehoe R, Kermiche S, Khalatyan N, Khanov A, Kharchilava A, Kharzheev YN, Khatidze D, Kim TJ, Kirby MH, Kirsch M, Klima B, Kohli JM, Konrath JP, Kozelov AV, Kraus J, Kuhl T, Kumar A, Kupco A, Kurca T, Kuzmin VA, Kvita J, Lacroix F, Lam D, Lammers S, Landsberg G, Lebrun P, Lee WM, Leflat A, Lellouch J, Li J, Li L, Li QZ, Lietti SM, Lim JK, Lincoln D, Linnemann J, Lipaev VV, Lipton R, Liu Y, Liu Z, Lobodenko A, Lokajicek M, Love P, Lubatti HJ, Luna-Garcia R, Lyon AL, Maciel AKA, Mackin D, Mättig P, Magaña-Villalba R, Magerkurth A, Mal PK, Malbouisson HB, Malik S, Malyshev VL, Maravin Y, Martin B, McCarthy R, McGivern CL, Meijer MM, Melnitchouk A, Mendoza L, Menezes D, Mercadante PG, Merkin M, Merritt KW, Meyer A, Meyer J, Mitrevski J, Mondal NK, Moore RW, Moulik T, Muanza GS, Mulhearn M, Mundal O, Mundim L, Nagy E, Naimuddin M, Narain M, Neal HA, Negret JP, Neustroev P, Nilsen H, Nogima H, Novaes SF, Nunnemann T, Obrant G, Ochando C, Onoprienko D, Orduna J, Oshima N, Osman N, Osta J, Otec R, Y Garzón GJO, Owen M, Padilla M, Padley P, Pangilinan M, Parashar N, Park SJ, Park SK, Parsons J, Partridge R, Parua N, Patwa A, Pawloski G, Penning B, Perfilov M, Peters K, Peters Y, Pétroff P, Piegaia R, Piper J, Pleier MA, Podesta-Lerma PLM, Podstavkov VM, Pogorelov Y, Pol ME, Polozov P, Popov AV, Prado da Silva WL, Protopopescu S, Qian J, Quadt A, Quinn B, Rakitine A, Rangel MS, Ranjan K, Ratoff PN, Renkel P, Rich P, Rijssenbeek M, Ripp-Baudot I, Rizatdinova F, Robinson S, Rominsky M, Royon C, Rubinov P, Ruchti R, Safronov G, Sajot G, Sánchez-Hernández A, Sanders MP, Sanghi B, Savage G, Sawyer L, Scanlon T, Schaile D, Schamberger RD, Scheglov Y, Schellman H, Schliephake T, Schlobohm S, Schwanenberger C, Schwienhorst R, Sekaric J, Severini H, Shabalina E, Shamim M, Shary V, Shchukin AA, Shivpuri RK, Siccardi V, Simak V, Sirotenko V, Skubic P, Slattery P, Smirnov D, Snow GR, Snow J, Snyder S, Söldner-Rembold S, Sonnenschein L, Sopczak A, Sosebee M, Soustruznik K, Spurlock B, Stark J, Stolin V, Stoyanova DA, Strandberg J, Strang MA, Strauss E, Strauss M, Ströhmer R, Strom D, Stutte L, Sumowidagdo S, Svoisky P, Takahashi M, Tanasijczuk A, Taylor W, Tiller B, Titov M, Tokmenin VV, Torchiani I, Tsybychev D, Tuchming B, Tully C, Tuts PM, Unalan R, Uvarov L, Uvarov S, Uzunyan S, van den Berg PJ, Van Kooten R, van Leeuwen WM, Varelas N, Varnes EW, Vasilyev IA, Verdier P, Vertogradov LS, Verzocchi M, Vilanova D, Vint P, Vokac P, Voutilainen M, Wagner R, Wahl HD, Wang MHLS, Warchol J, Watts G, Wayne M, Weber G, Weber M, Welty-Rieger L, Wenger A, Wetstein M, White A, Wicke D, Williams MRJ, Wilson GW, Wimpenny SJ, Wobisch M, Wood DR, Wyatt TR, Xie Y, Xu C, Yacoob S, Yamada R, Yang WC, Yasuda T, Yatsunenko YA, Ye Z, Yin H, Yip K, Yoo HD, Youn SW, Yu J, Zeitnitz C, Zelitch S, Zhao T, Zhou B, Zhu J, Zielinski M, Zieminska D, Zivkovic L, Zutshi V, Zverev EG. Search for next-to-minimal supersymmetric Higgs bosons in the h --> aa --> micromicromicromicro, micromicrotautau channels using pp[over] collisions at sqrt[s] = 1.96 TeV. PHYSICAL REVIEW LETTERS 2009; 103:061801. [PMID: 19792550 DOI: 10.1103/physrevlett.103.061801] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/21/2009] [Indexed: 05/28/2023]
Abstract
We report on a first search for production of the lightest neutral CP-even Higgs boson (h) in the next-to-minimal supersymmetric standard model, where h decays to a pair of neutral pseudoscalar Higgs bosons (a), using 4.2 fb;{-1} of data recorded with the D0 detector at Fermilab. The a bosons are required to either both decay to micro;{+}micro;{-} or one to micro;{+}micro;{-} and the other to tau;{+}tau;{-}. No significant signal is observed, and we set limits on its production as functions of M_{a} and M_{h}.
Collapse
|
1768
|
Cheng M, Hua W, Chen K, Pu J, Ren X, Zhao X, Liu Z, Wang F, Chen X, Zhang S. Perioperative anticoagulation for patients with mechanic heart valve(s) undertaking pacemaker implantation. Europace 2009; 11:1183-7. [DOI: 10.1093/europace/eup212] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
1769
|
Lan X, Su L, Ling Z, Liu Z, Wu J, Yang X, Zrenner B, Yin Y. Catheter ablation vs. amiodarone plus losartan for prevention of atrial fibrillation recurrence in patients with paroxysmal atrial fibrillation. Eur J Clin Invest 2009; 39:657-63. [PMID: 19490069 DOI: 10.1111/j.1365-2362.2009.02160.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
BACKGROUND Although amiodarone plus angiotensin II receptor blockers (ARBs) and catheter ablation may improve sinus rhythm maintenance of paroxysmal atrial fibrillation (AF), their clinical efficacies have not been compared. This prospective cohort study was designed to compare clinical efficacy of catheter ablation and amiodarone plus losartan on sinus rhythm maintenance in patients with paroxysmal AF. MATERIALS AND METHODS A total of 240 patients with paroxysmal AF were assigned to four groups. CPVA group (n = 60) was treated with circumferential pulmonary vein ablation (CPVA), SPVI group (n = 60) with segmental pulmonary vein isolation, AMIO group (n = 60) with amiodarone and AMIO + LO group (n = 60) with amiodarone plus losartan. The endpoint was documented recurrence of AF > 30 s by Holter or conventional 12-lead ECG in the 1-year follow-up period. RESULTS During 12 months of follow-up, the primary end point was reached in 28 patients in CPVA group, 14 patients in SPVI group, 25 patients in AMIO group and 13 patients in AMIO + LO group, respectively. The sinus rhythm in SPVI and AMIO + LO group were significant higher than that in CPVA and AMIO group (P < 0.01 and 0.025), and no difference between CPVA and AMIO group. The maintenance rate of sinus rhythm in SPVI group was similar to that in AMIO + LO group. CONCLUSIONS This study demonstrates that segmental pulmonary vein isolation in preventing AF recurrence is similar to amiodarone plus losartan, but it is superior to CPVA and amiodarone alone in patients with paroxysmal AF. Larger multicentre studies are needed to confirm its long-term outcomes.
Collapse
|
1770
|
Yamamoto T, Sakakibara R, Nakazawa K, Uchiyama T, Ito T, Liu Z, Shimizu E, Hattori T, Kuwabara S. P3.15 Dopamine D1 agonist inhibit the bladder contraction and change the activity of striatal bladder relaxation phase related neurons in cats. Auton Neurosci 2009. [DOI: 10.1016/j.autneu.2009.05.163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
1771
|
Heimbach L, Li N, Diaz A, Liu Z. Experimental animal models of bullous pemphigoid. GIORN ITAL DERMAT V 2009; 144:423-431. [PMID: 19755945] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
Bullous pemphigoid (BP) is a cutaneous autoimmune blistering disease characterized immunohistologically by dermal-epidermal junction separation, an inflammatory cell infiltrate in the upper dermis, and autoantibodies directed against the hemidesmosomal proteins BP230 and BP180. A passive transfer mouse model of BP that uses rabbit antibodies targeted against murine BP180 reproduces the key clinical and histological features of human BP. Using this model, it has been demonstrated that subepidermal blistering is initiated by anti-BP180 antibodies and mediated by complement activation, mast cell degranulation, neutrophil infiltration, and proteinase secretion. The rabbit-anti mouse IgG passive transfer model is not compatible with study of human pathogenic antibodies, as the human and murine antigenic epitopes are not cross-reactive. Two humanized mouse models in which the murine form of BP180 is replaced the human homologue have recently emerged. Autoantibodies isolated from human patients induce experimental BP in the humanized mice, and disease progression mirrors that observed in the rabbit-anti mouse IgG model. The humanized mouse models present ideal in vivo systems to test novel therapeutic strategies for disease management. In this review, we discuss the progress made in understanding the pathogenesis of BP, as well as the limits of using animal models to investigate human disease.
Collapse
|
1772
|
Lv J, Jia H, Jiang Y, Ruan Y, Liu Z, Yue W, Beyreuther K, Tu P, Zhang D. Tenuifolin, an extract derived from tenuigenin, inhibits amyloid-beta secretion in vitro. Acta Physiol (Oxf) 2009; 196:419-25. [PMID: 19208093 DOI: 10.1111/j.1748-1716.2009.01961.x] [Citation(s) in RCA: 51] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
AIM Previous studies have shown that tenuigenin, a crude extract of Polygala tenuifolia Willd. that is commonly used in traditional Chinese herbal medicine for memory loss, can reduce the secretion of Abeta from cultured cells. However, the mechanism underlying this effect and the active compound derived from tenuigenin is unknown. In this study, a purified component of tenuigenin, tenuifolin, was examined and revealed to be an effective compound in vitro. METHODS Abeta secretion from three sets of COS-7 cells, each carrying a plasmid expressing a different form of APP was examined following the treatment with tenuifolin. Initially, tenuifolin was determined to have no inherent toxicity to either the transfected or wild type cells at the effective concentrations. Cells were then treated with 0.5-2.0 microg mL(-1) tenuifolin for 12 h and their media were examined via an ELISA for Abeta1-40 and Abeta-42. RESULTS We found that treatment with 2.0 microg mL(-1) tenuifolin significantly decreased Abeta secretion from COS-7 cells without altering the ratio of Abeta1-40 and Abeta-42. This effect is most probably due to inhibition of the beta-site APP cleaving enzyme as Abeta secretion was not inhibited from cells expressing the C99 fragment. CONCLUSION Tenuifolin is an effective compound from tenuigenin. We believe that this finding should lead the way for future experiments to determine the exact mechanism for tenuifolin's effect on Abeta secretion.
Collapse
|
1773
|
Liu Z, Habener JF. Stromal cell-derived factor-1 promotes survival of pancreatic beta cells by the stabilisation of beta-catenin and activation of transcription factor 7-like 2 (TCF7L2). Diabetologia 2009; 52:1589-98. [PMID: 19468708 PMCID: PMC4085163 DOI: 10.1007/s00125-009-1384-x] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/18/2008] [Accepted: 04/03/2009] [Indexed: 01/09/2023]
Abstract
AIMS/HYPOTHESIS Stromal cell-derived factor-1 (SDF-1) is a chemokine produced in stromal tissues in multiple organs. Earlier we reported on levels of SDF-1 and SDF-1 receptor (CXCR4) in the insulin-producing beta cells of the mouse pancreas and determined that the SDF-1/CXCR4 axis is important for beta cell survival through activation of the prosurvival kinase, protein kinase B (AKT). Since AKT is known to modulate the wingless-type MMTV integration site family (WNT) signalling cascade, we examined the effects of SDF-1/CXCR4 on WNT signalling in beta cells and whether this signalling is important for cell survival. METHODS Activation of downstream WNT signalling (beta-catenin and transcription factor 7-like 2, [TCF7L2]) in response to SDF-1 was examined in the islets of WNT signalling reporter (Tcf-optimal promoter beta-galactosidase) mice and in INS-1 and MIN6 beta cells. Cytoprotection of beta cells by SDF-1 in response to the induction of apoptosis was assessed by caspase 3 and TUNEL assays. RESULTS SDF-1 induced WNT signalling in beta cells of isolated islets and in INS-1 cells via CXCR4-mediated activation of Galphai/o-coupled signalling and the phosphatidylinositol 3-kinase/AKT signalling cascade resulting in the inhibition of glycogen synthase kinase 3-beta. The key WNT signalling regulators, beta-catenin and AKT, were activated by SDF-1 at the transcriptional and post-translational levels. Specific inhibition of beta-catenin in the WNT signalling cascade reversed the anti-apoptotic effects of SDF-1. CONCLUSIONS/INTERPRETATION SDF-1 promotes pancreatic beta cell survival via activation of AKT and downstream WNT signalling via the stabilisation and activation of beta-catenin/TCF7L2 transcriptional activators. These findings suggest a mechanism for SDF-1 based glucose-lowering therapies by enhancing beta cell mass through increasing cell survival.
Collapse
|
1774
|
Liu Z, Otto-Bliesner BL, He F, Brady EC, Tomas R, Clark PU, Carlson AE, Lynch-Stieglitz J, Curry W, Brook E, Erickson D, Jacob R, Kutzbach J, Cheng J. Transient simulation of last deglaciation with a new mechanism for Bolling-Allerod warming. Science 2009; 325:310-4. [PMID: 19608916 DOI: 10.1126/science.1171041] [Citation(s) in RCA: 178] [Impact Index Per Article: 11.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Abstract
We conducted the first synchronously coupled atmosphere-ocean general circulation model simulation from the Last Glacial Maximum to the Bølling-Allerød (BA) warming. Our model reproduces several major features of the deglacial climate evolution, suggesting a good agreement in climate sensitivity between the model and observations. In particular, our model simulates the abrupt BA warming as a transient response of the Atlantic meridional overturning circulation (AMOC) to a sudden termination of freshwater discharge to the North Atlantic before the BA. In contrast to previous mechanisms that invoke AMOC multiple equilibrium and Southern Hemisphere climate forcing, we propose that the BA transition is caused by the superposition of climatic responses to the transient CO(2) forcing, the AMOC recovery from Heinrich Event 1, and an AMOC overshoot.
Collapse
|
1775
|
Zuo YG, Song P, Liu Z, Ho MG, Liu YH, Wang HW, Jin HZ, Sun QN. Lack of evidence for OSMR and RET gene mutations in a Chinese family with friction melanosis. Clin Exp Dermatol 2009; 35:282-6. [PMID: 19594765 DOI: 10.1111/j.1365-2230.2009.03426.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
BACKGROUND Friction melanosis (FM) is a common dermatological disorder. Although cases have been reported, familial FM is rare. FM and macular amyloidosis (MA) have been hypothesized to be identical clinical conditions, and cutaneous lichen amyloidosis (CLA) is linked to mutations in the OSMR (oncostatin M receptor) or RET (receptor tyrosine kinase) genes. AIM To evaluate the OSMR and RET gene mutations in a Chinese family with FM. Methods. We investigated a family with FM with six affected members in four successive generations. All 17 exons of the OSMR and 19 exons of the RET genes were screened for mutation by PCR, and restriction enzyme digestion assays for RET codon 634 mutations were performed for selected members of the family. RESULTS Based on the pedigree characteristics, we suggest an autosomal dominant mode of inheritance in this FM family. We did not detect any mutations in the OSMR or RET genes. CONCLUSIONS We report a rare case of familial FM. Genes other than OSMR and RET may be involved in the pathogenesis of this family.
Collapse
|